Exact Mass: 550.3270526
Exact Mass Matches: 550.3270526
Found 437 metabolites which its exact mass value is equals to given mass value 550.3270526,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Desglucocheirotoxin
Convallatoxin is a cardenolide glycoside that consists of strophanthidin having a 6-deoxy-alpha-L-mannopyranosyl (L-rhamnosyl) group attached at position 3. It has a role as a vasodilator agent and a metabolite. It is an alpha-L-rhamnoside, a 19-oxo steroid, a 14beta-hydroxy steroid, a 5beta-hydroxy steroid, a steroid lactone and a steroid aldehyde. It is functionally related to a strophanthidin. Convallatoxin is a natural product found in Crossosoma bigelovii, Convallaria keiskei, and other organisms with data available. Convallatoxin is a glycoside extracted from Convallaria majalis. Convallatoxin is also isolated from the trunk bark of Antiaris toxicaria (A15340). Convallatoxin is a constituent of Convallaria majalis. Convallaria majalis has been designated unsafe for inclusion in foods etc. by USA FDA Constituent of Convallaria majalis. Convallaria majalis has been designated unsafe for inclusion in foods etc. by USA FDA. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D013328 - Strophanthins D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Convallatoxin is a cardiac glycoside isolated from Adonis amurensis Regel et Radde. Convallatoxin ameliorates colitic inflammation via activation of PPARγ and suppression of NF-κB. Convallatoxin is a P-glycoprotein (P-gp) substrate and recognized Val982 as an important amino acid involved in its transport. Convallatoxin is an enhancer of ligand-induced MOR endocytosis with high potency and efficacy. Anti-inflammatory and anti-proliferative properties[1][2][3]. Convallatoxin is a cardiac glycoside isolated from Adonis amurensis Regel et Radde. Convallatoxin ameliorates colitic inflammation via activation of PPARγ and suppression of NF-κB. Convallatoxin is a P-glycoprotein (P-gp) substrate and recognized Val982 as an important amino acid involved in its transport. Convallatoxin is an enhancer of ligand-induced MOR endocytosis with high potency and efficacy. Anti-inflammatory and anti-proliferative properties[1][2][3].
Hordatine A
A member of the calss of benzofurans that is a homodimer of para-coumarylagmatine where a hydroxy group of one molecule has reacted across the other molecules ethene double bond to combine the two molecules and form a furan ring.
Adonitoxin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides
PA(8:0/17:0)
PA(8:0/17:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/17:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of margaric acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(10:0/a-15:0)
PA(10:0/a-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/a-15:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of anteisopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(10:0/i-15:0)
PA(10:0/i-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/i-15:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of isopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(8:0/a-17:0)
PA(8:0/a-17:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/a-17:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of anteisoheptadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(8:0/i-17:0)
PA(8:0/i-17:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/i-17:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of isoheptadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(a-13:0/i-12:0)
PA(a-13:0/i-12:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-13:0/i-12:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of isododecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-12:0/a-13:0)
PA(i-12:0/a-13:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/a-13:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of anteisotridecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-12:0/i-13:0)
PA(i-12:0/i-13:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/i-13:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of isotridecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-13:0/i-12:0)
PA(i-13:0/i-12:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-13:0/i-12:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position and one chain of isododecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
DG(8:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)
DG(8:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/8:0/0:0)
DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))
DG(8:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/8:0)
DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
3alpha-Angeloyloxy-2beta,15-dihydroxy-ent-labda-7,13E-dien-2-O-beta-fucopyranoside
3-[5,14-dihydroxy-3-(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy-10-(hydroxymethyl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
5beta-acetoxy-4beta,8-diangeloyloxy-2beta,3beta-epoxy-10-hydroxy-11-isopropoxy-bisabol-7(14)-ene
digitoxigenin-3-O-beta-D-(3-O-methyl)glucopyranoside
(+)-20S-2alpha-hydroxy-20-(dimethylamino)-3beta-phthalimido-5alpha-pregnan-4beta-yl acetate
N,N-dimethyl-L-isoleucine (4S)-7t-((R)-hydroxy-phenyl-methyl)-3t-isopropyl-5,8-dioxo-2-oxa-6,9-diaza-1(1,4)-benzena-cycloundecaphan-10c-en-4r-ylamide|Scutianin H|scutianine-H
3-[(6-deoxy-3-O-methylhexopyranosyl)oxy]-14,16-dihydroxycard-20(22)-enolide
19-Aldehyde,3-O-beta-D-allomethyloside-(3beta,5alpha,14beta,17betaOH)-3,14,17,19-Tetrahydroxycard-20(22)-enolide
(20R)-18,20-epoxy-digitoxigenin alpha-L-thevetoside|(20S)-18,20-epoxydigitoxigenin alpha-L-thevetoside
3beta,8beta-diangeloyloxy-5alpha,9beta-diacetoxy-4alpha-hydroxy-1beta,10alpha-epoxygermacr-11-ene
17-benzoyloxy-3-O-(2,3-dimethylbutanoyl)-20-deoxyingenol
14,19-dihydroxy-3beta-(O3-methyl-6-deoxy-alpha-L-glucopyranosyloxy)-5beta,14beta-card-20(22)-enolide|14,19-Dihydroxy-3beta-(O3-methyl-6-desoxy-alpha-L-glucopyranosyloxy)-5beta,14beta-card-20(22)-enolid|Ruvoside
4-O-(nonadecanoyl)apigenin|4-(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl)phenyl nonadecanoate|ziziphorin A
12alpha-ethoxyl-1alpha,6alpha,7beta-triacetoxy-5alpha,14beta-dihydroxy-cass-13(15)-en-16,12-olide
antiaroside E
Convallatoxin
Convallatoxin is a cardenolide glycoside that consists of strophanthidin having a 6-deoxy-alpha-L-mannopyranosyl (L-rhamnosyl) group attached at position 3. It has a role as a vasodilator agent and a metabolite. It is an alpha-L-rhamnoside, a 19-oxo steroid, a 14beta-hydroxy steroid, a 5beta-hydroxy steroid, a steroid lactone and a steroid aldehyde. It is functionally related to a strophanthidin. Convallatoxin is a natural product found in Crossosoma bigelovii, Convallaria keiskei, and other organisms with data available. Convallatoxin is a glycoside extracted from Convallaria majalis. Convallatoxin is also isolated from the trunk bark of Antiaris toxicaria (A15340). A cardenolide glycoside that consists of strophanthidin having a 6-deoxy-alpha-L-mannopyranosyl (L-rhamnosyl) group attached at position 3. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D013328 - Strophanthins D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Convallatoxin is a cardiac glycoside isolated from Adonis amurensis Regel et Radde. Convallatoxin ameliorates colitic inflammation via activation of PPARγ and suppression of NF-κB. Convallatoxin is a P-glycoprotein (P-gp) substrate and recognized Val982 as an important amino acid involved in its transport. Convallatoxin is an enhancer of ligand-induced MOR endocytosis with high potency and efficacy. Anti-inflammatory and anti-proliferative properties[1][2][3]. Convallatoxin is a cardiac glycoside isolated from Adonis amurensis Regel et Radde. Convallatoxin ameliorates colitic inflammation via activation of PPARγ and suppression of NF-κB. Convallatoxin is a P-glycoprotein (P-gp) substrate and recognized Val982 as an important amino acid involved in its transport. Convallatoxin is an enhancer of ligand-induced MOR endocytosis with high potency and efficacy. Anti-inflammatory and anti-proliferative properties[1][2][3].
(1R*,2R*,3E,7E,11R*,12S*)-2,18-O-diacetyl-16-O-(3-hydroxy-3-methylglutaryl)-dolabella-3,7-dien-2,16,18-triol
3beta,-angeloyloxy-5alpha,9beta-diacetoxy-4alpha-hydroxy-8beta-senecioyloxy-1beta,10alpha-epoxygermacr-11-ene
corotoxigenin 3beta-D-glucoside|Cortoxigenin-3-beta-D-glucosid|glucocorotoxigenin
5-Ene-methyl-7,12-didehydroxy-cholate-3-O-??-D-glucopyranoside
Tyr Ile Lys Lys
Lys Glu Phe Lys
Phe Lys Glu Lys
Lys Phe Glu Lys
Phe Thr Arg Lys
C30H46O9_(3beta,5beta)-3-[(2,6-Dideoxy-3-O-methyl-beta-D-ribo-hexopyranosyl)oxy]-5,14,19-trihydroxycard-20(22)-enolide
Ala Phe Lys Trp
C29H38N6O5 (550.2903537999999)
Ala Phe Trp Lys
C29H38N6O5 (550.2903537999999)
Ala Lys Phe Trp
C29H38N6O5 (550.2903537999999)
Ala Lys Trp Phe
C29H38N6O5 (550.2903537999999)
Ala Trp Phe Lys
C29H38N6O5 (550.2903537999999)
Ala Trp Lys Phe
C29H38N6O5 (550.2903537999999)
Glu Phe Lys Lys
Glu Lys Phe Lys
Glu Lys Lys Phe
Phe Ala Lys Trp
C29H38N6O5 (550.2903537999999)
Phe Ala Trp Lys
C29H38N6O5 (550.2903537999999)
Phe Glu Lys Lys
Phe Lys Ala Trp
C29H38N6O5 (550.2903537999999)
Phe Lys Lys Glu
Phe Lys Arg Thr
Phe Lys Thr Arg
Phe Lys Trp Ala
C29H38N6O5 (550.2903537999999)
Phe Gln Arg Thr
Phe Gln Thr Arg
Phe Arg Lys Thr
Phe Arg Gln Thr
Phe Arg Thr Lys
Phe Arg Thr Gln
Phe Thr Lys Arg
Phe Thr Gln Arg
Phe Thr Arg Gln
Phe Trp Ala Lys
C29H38N6O5 (550.2903537999999)
Phe Trp Lys Ala
C29H38N6O5 (550.2903537999999)
Gly Arg Arg Tyr
C23H38N10O6 (550.2975647999999)
Gly Arg Tyr Arg
C23H38N10O6 (550.2975647999999)
Gly Tyr Arg Arg
C23H38N10O6 (550.2975647999999)
Ile Lys Lys Tyr
Ile Lys Gln Tyr
Ile Lys Tyr Lys
Ile Lys Tyr Gln
Ile Gln Lys Tyr
Ile Gln Tyr Lys
Ile Tyr Lys Lys
Ile Tyr Lys Gln
Ile Tyr Gln Lys
Lys Ala Phe Trp
C29H38N6O5 (550.2903537999999)
Lys Ala Trp Phe
C29H38N6O5 (550.2903537999999)
Lys Glu Lys Phe
Lys Phe Ala Trp
C29H38N6O5 (550.2903537999999)
Lys Phe Lys Glu
Lys Phe Arg Thr
Lys Phe Thr Arg
Lys Phe Trp Ala
C29H38N6O5 (550.2903537999999)
Lys Ile Lys Tyr
Lys Ile Gln Tyr
Lys Ile Tyr Lys
Lys Ile Tyr Gln
Lys Lys Glu Phe
Lys Lys Phe Glu
Lys Lys Ile Tyr
Lys Lys Leu Tyr
Lys Lys Tyr Ile
Lys Lys Tyr Leu
Lys Leu Lys Tyr
Lys Leu Gln Tyr
Lys Leu Tyr Lys
Lys Leu Tyr Gln
Lys Gln Ile Tyr
Lys Gln Leu Tyr
Lys Gln Tyr Ile
Lys Gln Tyr Leu
Lys Arg Phe Thr
Lys Arg Thr Phe
Lys Thr Phe Arg
Lys Thr Arg Phe
Lys Trp Ala Phe
C29H38N6O5 (550.2903537999999)
Lys Trp Phe Ala
C29H38N6O5 (550.2903537999999)
Lys Tyr Ile Lys
Lys Tyr Ile Gln
Lys Tyr Lys Ile
Lys Tyr Lys Leu
Lys Tyr Leu Lys
Lys Tyr Leu Gln
Lys Tyr Gln Ile
Lys Tyr Gln Leu
Leu Lys Lys Tyr
Leu Lys Gln Tyr
Leu Lys Tyr Lys
Leu Lys Tyr Gln
Leu Gln Lys Tyr
Leu Gln Tyr Lys
Leu Tyr Lys Lys
Leu Tyr Lys Gln
Leu Tyr Gln Lys
Asn Arg Val Tyr
Asn Arg Tyr Val
Asn Val Arg Tyr
Asn Val Tyr Arg
Asn Tyr Arg Val
Asn Tyr Val Arg
Gln Phe Arg Thr
Gln Phe Thr Arg
Gln Ile Lys Tyr
Gln Ile Tyr Lys
Gln Lys Ile Tyr
Gln Lys Leu Tyr
Gln Lys Tyr Ile
Gln Lys Tyr Leu
Gln Leu Lys Tyr
Gln Leu Tyr Lys
Gln Arg Phe Thr
Gln Arg Thr Phe
Gln Thr Phe Arg
Gln Thr Arg Phe
Gln Tyr Ile Lys
Gln Tyr Lys Ile
Gln Tyr Lys Leu
Gln Tyr Leu Lys
Arg Phe Lys Thr
Arg Phe Gln Thr
Arg Phe Thr Lys
Arg Phe Thr Gln
Arg Gly Arg Tyr
C23H38N10O6 (550.2975647999999)
Arg Gly Tyr Arg
C23H38N10O6 (550.2975647999999)
Arg Lys Phe Thr
Arg Lys Thr Phe
Arg Asn Val Tyr
Arg Asn Tyr Val
Arg Gln Phe Thr
Arg Gln Thr Phe
Arg Arg Gly Tyr
C23H38N10O6 (550.2975647999999)
Arg Arg Tyr Gly
C23H38N10O6 (550.2975647999999)
Arg Thr Phe Lys
Arg Thr Phe Gln
Arg Thr Lys Phe
Arg Thr Gln Phe
Arg Val Asn Tyr
Arg Val Tyr Asn
Arg Tyr Gly Arg
C23H38N10O6 (550.2975647999999)
Arg Tyr Asn Val
Arg Tyr Arg Gly
C23H38N10O6 (550.2975647999999)
Arg Tyr Val Asn
Thr Phe Lys Arg
Thr Phe Gln Arg
Thr Phe Arg Lys
Thr Phe Arg Gln
Thr Lys Phe Arg
Thr Lys Arg Phe
Thr Gln Phe Arg
Thr Gln Arg Phe
Thr Arg Phe Lys
Thr Arg Phe Gln
Thr Arg Lys Phe
Thr Arg Gln Phe
Val Asn Arg Tyr
Val Asn Tyr Arg
Val Arg Asn Tyr
Val Arg Tyr Asn
Val Tyr Asn Arg
Val Tyr Arg Asn
Trp Ala Phe Lys
C29H38N6O5 (550.2903537999999)
Trp Ala Lys Phe
C29H38N6O5 (550.2903537999999)
Trp Phe Ala Lys
C29H38N6O5 (550.2903537999999)
Trp Phe Lys Ala
C29H38N6O5 (550.2903537999999)
Trp Lys Ala Phe
C29H38N6O5 (550.2903537999999)
Trp Lys Phe Ala
C29H38N6O5 (550.2903537999999)
Tyr Gly Arg Arg
C23H38N10O6 (550.2975647999999)
Tyr Ile Lys Gln
Tyr Ile Gln Lys
Tyr Lys Ile Lys
Tyr Lys Ile Gln
Tyr Lys Lys Ile
Tyr Lys Lys Leu
Tyr Lys Leu Lys
Tyr Lys Leu Gln
Tyr Lys Gln Ile
Tyr Lys Gln Leu
Tyr Leu Lys Lys
Tyr Leu Lys Gln
Tyr Leu Gln Lys
Tyr Asn Arg Val
Tyr Asn Val Arg
Tyr Gln Ile Lys
Tyr Gln Lys Ile
Tyr Gln Lys Leu
Tyr Gln Leu Lys
Tyr Arg Gly Arg
C23H38N10O6 (550.2975647999999)
Tyr Arg Asn Val
Tyr Arg Arg Gly
C23H38N10O6 (550.2975647999999)
Tyr Arg Val Asn
Tyr Val Asn Arg
Tyr Val Arg Asn
glas#26
An ascarosyloxycarboxylic acid beta-D-glucopyranosyl ester resulting from the formal esterification of the carboxy group of ascr#26 with the anomeric hydroxy group of beta-D-glucopyranose. It is a metabolite of the nematode Caenorhabditis elegans.
PHOHA-PA
C26H47O10P (550.2906691999999)
Antiaroside C
Cymarol
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D013328 - Strophanthins
R-3,3-Bis(4-(1,1-dimethylethyl)phenyl)-1,1-bi-2-naphthol
(S)-4-(2-amino-3-((2-aminoethyl)amino)propyl)phenol hydrochloride
Strospeside
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides
3beta-(6-deoxy-3-O-methyl-alpha-L-talopyranosyloxy)-1beta,14-dihydroxy-5beta-card-20(22)-enolide
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides
1-O-{(14R)-14-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]pentadecanoyl}-beta-D-glucopyranose
N-[4-(diaminomethylideneamino)butyl]-5-[(E)-3-[4-(diaminomethylideneamino)butylamino]-3-oxoprop-1-enyl]-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-3-carboxamide
[(4S)-4-[[(2S)-2-amino-4-methylpentanoyl]amino]-5-[[(2S,3S,6R)-6-(4-amino-2-oxopyrimidin-1-yl)-2-carboxy-3,6-dihydro-2H-pyran-3-yl]amino]-3-methyl-5-oxopentyl]-(diaminomethylidene)-methylazanium
Ajugapitin
A diterpenoid isolated from the aerial parts of Ajuga bracteosa and has been shown to exhibit antifeedant activity against Spodoptera littoralis.
3alpha-(beta-D-glucopyranuronosyloxy)-5beta-cholan-24-oate
1-cyclohexyl-3-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C32H46N4O4 (550.3518875999999)
1-cyclohexyl-3-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C32H46N4O4 (550.3518875999999)
1-cyclohexyl-3-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C32H46N4O4 (550.3518875999999)
1-cyclohexyl-3-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C32H46N4O4 (550.3518875999999)
1-cyclohexyl-3-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C32H46N4O4 (550.3518875999999)
N-[(2R,3R)-2-[[[(cyclohexylamino)-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide
1-cyclohexyl-3-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C32H46N4O4 (550.3518875999999)
1-cyclohexyl-3-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C32H46N4O4 (550.3518875999999)
1-cyclohexyl-3-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C32H46N4O4 (550.3518875999999)
2-methoxy-N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[(5-phenyl-3-isoxazolyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
2,3,7,7,12,13,17,18-Octaethyl-21H,23H-porphine-8-one
[(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate
2-[(2S,3R,4S,5R)-5-[[4-[[benzyl(methyl)amino]methyl]triazol-1-yl]methyl]-3,4-dihydroxyoxolan-2-yl]-1-[4-(2-methoxyphenyl)piperazin-1-yl]ethanone
C29H38N6O5 (550.2903537999999)
2-[[(2R)-3-hexadecanoyloxy-2-prop-2-enoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2,3-dihydroxypropyl [3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-hydroxypropyl] hydrogen phosphate
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (11Z,14Z)-henicosa-11,14-dienoate
[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
C26H47O10P (550.2906691999999)
[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate
C26H47O10P (550.2906691999999)
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate
C26H47O10P (550.2906691999999)
(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) hexadecanoate
(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) octadecanoate
(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) icosanoate
[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
C26H47O10P (550.2906691999999)
[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate
C26H47O10P (550.2906691999999)
(1-Butanoyloxy-3-phosphonooxypropan-2-yl) henicosanoate
(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) nonadecanoate
(1-Phosphonooxy-3-propanoyloxypropan-2-yl) docosanoate
(1-Acetyloxy-3-phosphonooxypropan-2-yl) tricosanoate
(1-Octanoyloxy-3-phosphonooxypropan-2-yl) heptadecanoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate
C26H47O10P (550.2906691999999)
(1-Phosphonooxy-3-undecanoyloxypropan-2-yl) tetradecanoate
(1-Dodecanoyloxy-3-phosphonooxypropan-2-yl) tridecanoate
(1-Decanoyloxy-3-phosphonooxypropan-2-yl) pentadecanoate
[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] tetradecanoate
[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] tetradecanoate
[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropyl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate
[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate
[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] pentadecanoate
[(2R)-2-decanoyloxy-3-phosphonooxypropyl] pentadecanoate
2-[[3-hexanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[1-carboxy-3-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-pentanoyloxypropoxy]propyl]-trimethylazanium
2-[[2-[(Z)-hexadec-9-enoyl]oxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-pentanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
[1-carboxy-3-[2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-propanoyloxypropoxy]propyl]-trimethylazanium
2-[[3-butanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-acetyloxy-2-[(Z)-heptadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
Desglucocheirotoxin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D013328 - Strophanthins
[(2R)-2-(10-methylundecanoyloxy)-3-phosphonooxypropyl] 11-methyldodecanoate
1-(9Z-octadecenoyl)-2-glutaryl-sn-glycero-3-phosphate
C26H47O10P (550.2906691999999)
lithocholate 3-O-(beta-D-glucuronide)(2-)
A steroid glucuronide anion that is the conjugate base of lithocholic acid 3-O-(beta-D-glucuronide) arising from deprotonation of the carboxylic acid functions; major species at pH 7.3.